Google News

Professor James Galloway, honorary consultant rheumatologist and deputy director of the Centre for Rheumatic … rheumatology services. SUGGESTED FOR …

Autolus Therapeutics announces the online publication of an abstract for the American College of Rheumatology Convergence 2025. The abstract …

… rheumatic diseases, offering an accessible, convenient way to address mental health needs in rheumatology. Written for you by our

… Rheumatology (ACR) Convergence 2025, to be held October 24-29, 2025, in Chicago. Autolus will have a poster presentation, which

Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology (ACR) Convergence 2025. Rhea-AI Impact. (Low). Rhea-AI …

The new study in the Annals of the Rheumatic Diseases, published by Elsevier, is poised to inform targeted public health

… Rheumatology and Musculoskeletal Epidemiology, University of Sydney and Kolling Institute, Australia. … Rheumatic Diseases. /Public Release …

… Rheumatology and Musculoskeletal Epidemiology, University of Sydney and Kolling Institute, Australia. … Rheumatic Diseases. More information …

The 3 ways Lupus can affect your hands – a Rheumatologist explains. Connected Rheumatology•334K views · 15:38 · Go to

The results published in American College of Rheumatology, suggest that … Rheumatology & Arthritis Newsletter. Brand/Meeting. Advertisement …

The two day event titled ‘3rd International Pediatric Rheumatology Conference- 2019′ ended at Bangabandhu Sheikh Mujib Medical University on Sunday.

Patients with isolated PMR or GCA in Norway had all-cause mortality rates that were similar to members of the general

In this Healio video, Philip J. Mease, MD, director of rheumatology research at Providence Swedish Medical Center in Seattle, discusses

… rheumatologist at Unity Health in Searcy, Arkansas, and past president of the Arkansas Rheumatology Association. This recurring sleep-pain cycle …

SPY072 is an investigational, extended half-life monoclonal antibody targeting TL1A for the potential treatment of rheumatic diseases including …

The 3 ways Lupus can affect your hands – a Rheumatologist explains. Connected Rheumatology•334K views · 19:09 · Go to

The Rheumatology Fellowship in Rochester, Minnesota, is a two-year program with an optional third year for those pursuing academic careers.

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in

The rheumatic conditions targeted by the SKYWAY trial affect more than 3 million individuals in the United States, according to

SPY072 is a potential first- and best-in-class anti-TL1A antibody for rheumatic diseases targeting quarterly or twice-yearly subcutaneous dosing …

… 2 SKYWAY basket trial of SPY072, the first anti-TL1A antibody studied in rheumatic diseases … -September 15, 2025 at

On examination, spinal mobility was reduced, but there were no neurological deficits. Laboratory tests revealed an elevated C-reactive protein level …

Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial. September 15, 2025 8:00 AM. Spyre Therapeutics Inc. (NASDAQ:

Arish Mudra Rakshasa-Loots, PhD, can be reached at Arish.MRL@ed.ac.uk. Published by: healio rheumatology logo. Sources/Disclosures. Collapse. Source …

Press release – The Business Research Company – Unlocking Opportunities in the Rheumatology Therapeutics Market: 2025-2034 Forecast Report …

The FDA’s decision to scrap a little used panel of arthritis experts due to its cost draws criticism from those

… rheumatic drugs for rheumatoid arthritis. Rheumatology (Oxford). 2022;61(12):4678-4686. doi:10.1093/rheumatology/keac190. 4. Guo Y, Walsh AM …